Department of Molecular Genetics, University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute, P.O. Box 14, 9750 AA Haren, The Netherlands.
Antimicrob Agents Chemother. 2010 Apr;54(4):1498-505. doi: 10.1128/AAC.00883-09. Epub 2010 Jan 25.
Recent studies showed that the nisin modification machinery can successfully dehydrate serines and threonines and introduce lanthionine rings in small peptides that are fused to the nisin leader sequence. This opens up exciting possibilities to produce and engineer larger antimicrobial peptides in vivo. Here we demonstrate the exploitation of the class I nisin production machinery to generate, modify, and secrete biologically active, previously not-yet-isolated and -characterized class II two-component lantibiotics that have no sequence homology to nisin. The nisin synthesis machinery, composed of the modification enzymes NisB and NisC and the transporter NisT, was used to modify and secrete a putative two-component lantibiotic of Streptococcus pneumoniae. This was achieved by genetically fusing the propeptide-encoding sequences of the spr1765 (pneA1) and spr1766 (pneA2) genes to the nisin leader-encoding sequence. The chimeric prepeptides were secreted out of Lactococcus lactis, purified by cation exchange fast protein liquid chromatography, and further characterized. Mass spectrometry analyses demonstrated the presence and partial localization of multiple dehydrated serines and/or threonines and (methyl)lanthionines in both peptides. Moreover, after cleavage of the leader peptide from the prepeptides, both modified propeptides displayed antimicrobial activity against Micrococcus flavus. These results demonstrate that the nisin synthetase machinery can be successfully used to modify and produce otherwise difficult to obtain antimicrobially active lantibiotics.
最近的研究表明,乳链菌肽修饰机制能够成功地使丝氨酸和苏氨酸脱水,并在与乳链菌肽前导序列融合的小肽中引入类硫醚键。这为在体内生产和工程改造更大的抗菌肽开辟了令人兴奋的可能性。在这里,我们展示了利用 I 类乳链菌肽生产机制来产生、修饰和分泌具有生物活性的、以前尚未分离和表征的、与乳链菌肽没有序列同源性的 II 类双组分类硫醚抗生素。由修饰酶 NisB 和 NisC 以及转运蛋白 NisT 组成的乳链菌肽合成机制被用于修饰和分泌肺炎链球菌的一种假定的双组分类硫醚抗生素。这是通过将 spr1765(pneA1)和 spr1766(pneA2)基因的前肽编码序列与乳链菌肽前导序列编码序列进行基因融合来实现的。嵌合前肽从乳链球菌中分泌出来,通过阳离子交换快速蛋白液相色谱法进行纯化,并进一步进行了表征。质谱分析表明,两种肽中都存在多个脱水丝氨酸和/或苏氨酸和(甲基)类硫醚键,并且部分定位。此外,在前肽从预肽中切割后,两种修饰的前肽都显示出对黄色微球菌的抗菌活性。这些结果表明,乳链菌肽合成酶机制可以成功地用于修饰和生产其他难以获得的抗菌活性的类硫醚抗生素。